Global Multimodal Imaging Market is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2023-2030. Multimodal imaging is used to research the structure and functioning of the placenta as well as other traits including embryo development. These studies are often carried out in transgenic mice. The function and architecture of the foetal and maternal vascular systems, as well as the structure and internal exchanges of the placenta, may all be improved with the use of newly developed imaging tools. Significant development in Multimodal Imaging market due to growing Prevalence of Chronic Illness and rise in the healthcare expenditure.
According to Statista, the projected number of chronic illness patients in Italy between 2028 and 2038. Data indicate that 25,233 thousand people might have at least one chronic ailment by 2028, compared to 13,907 thousand people who could have at least two chronic illnesses in the same year. By 2038, 14,673 thousand Italians are expected to be concerned about two or more chronic illnesses. Furthermore, The American Cancer Society predicts that in 2019, there will be around 606,880 cancer-related deaths in the United States, or 1,660 each day. The market is booming in the area as a result of the rising prevalence of chronic illnesses and the quick uptake of technologically sophisticated imaging devices. Moreover, increasing usage in the non-invasive diagnostic procedures and availability of advanced healthcare infrastructure create lucrative opportunities in the upcoming years. However, lack of appropriate healthcare infrastructure and high price of the multimodal imaging system stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Multimodal Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the global market share owing to increase in the aging population, rise in the healthcare expenditure. However, Asia Pacific is expected to be the fastest growing region due to rising development related to new imaging technique and rising healthcare industry.
Major market player included in this report are:
- Topcon Corporation
- Siemens Healthineers
- Neusoft Medical Systems Co. Ltd.
- United Imaging Healthcare Co. Ltd.
- Infraredx Inc.
- Koninklijke Philips N.V.
- Canon Inc.
- Mediso Medical Imaging Systems Kft
- GE Healthcare
- Spectrum Dynamics Medical
Recent Developments in the Market:
- January 2019, the uEXPLORER complete body PET/CT technology was unveiled by United Imaging Healthcare Co., Ltd. The objective of uEXPLORER is to transform molecular imaging by switching from conventional whole-body PET/CT imaging to simultaneous total-body imaging.
Global Multimodal Imaging Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimation: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Technology, Application, End-user, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
- PET/CT Systems
- SPECT/CT Systems
- PET/MR Systems
- Others
By Application:
- Oncology
- Ophthalmology
- Cardiology
- Others
By End-user:
- Hospitals
- Diagnostic Centers
- Others
By Region:
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Multimodal Imaging Market, by region, 2020-2030 (USD Billion)
- 1.2.2. Multimodal Imaging Market, by Technology, 2020-2030 (USD Billion)
- 1.2.3. Multimodal Imaging Market, by Application, 2020-2030 (USD Billion)
- 1.2.4. Multimodal Imaging Market, by End-user, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Multimodal Imaging Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Multimodal Imaging Market Dynamics
- 3.1. Multimodal Imaging Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Growing Prevalence of Chronic illnesses
- 3.1.1.2. Rise in the healthcare expenditure
- 3.1.2. Market Challenges
- 3.1.2.1. Lack of appropriate healthcare infrastructure
- 3.1.2.2. High price of the multimodal imaging system
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing usage in the non-invasive diagnostic procedures
- 3.1.3.2. Availability of advanced healthcare infrastructure
Chapter 4. Global Multimodal Imaging Market: Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Multimodal Imaging Market, by Technology
- 5.1. Market Snapshot
- 5.2. Global Multimodal Imaging Market by Technology, Performance - Potential Analysis
- 5.3. Global Multimodal Imaging Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
- 5.4. Multimodal Imaging Market, Sub Segment Analysis
- 5.4.1. PET/CT Systems
- 5.4.2. SPECT/CT Systems
- 5.4.3. PET/MR Systems
- 5.4.4. Others
Chapter 6. Global Multimodal Imaging Market, by Application
- 6.1. Market Snapshot
- 6.2. Global Multimodal Imaging Market by Application, Performance - Potential Analysis
- 6.3. Global Multimodal Imaging Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
- 6.4. Multimodal Imaging Market, Sub Segment Analysis
- 6.4.1. Oncology
- 6.4.2. Ophthalmology
- 6.4.3. Cardiology
- 6.4.4. Others
Chapter 7. Global Multimodal Imaging Market, by End-user
- 7.1. Market Snapshot
- 7.2. Global Multimodal Imaging Market by End-user, Performance - Potential Analysis
- 7.3. Global Multimodal Imaging Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
- 7.4. Multimodal Imaging Market, Sub Segment Analysis
- 7.4.1. Hospitals
- 7.4.2. Diagnostic Centers
- 7.4.3. Others
Chapter 8. Global Multimodal Imaging Market, Regional Analysis
- 8.1. Top Leading Countries
- 8.2. Top Emerging Countries
- 8.3. Multimodal Imaging Market, Regional Market Snapshot
- 8.4. North America Multimodal Imaging Market
- 8.4.1. U.S. Multimodal Imaging Market
- 8.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
- 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 8.4.1.3. End-user breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Multimodal Imaging Market
- 8.5. Europe Multimodal Imaging Market Snapshot
- 8.5.1. U.K. Multimodal Imaging Market
- 8.5.2. Germany Multimodal Imaging Market
- 8.5.3. France Multimodal Imaging Market
- 8.5.4. Spain Multimodal Imaging Market
- 8.5.5. Italy Multimodal Imaging Market
- 8.5.6. Rest of Europe Multimodal Imaging Market
- 8.6. Asia-Pacific Multimodal Imaging Market Snapshot
- 8.6.1. China Multimodal Imaging Market
- 8.6.2. India Multimodal Imaging Market
- 8.6.3. Japan Multimodal Imaging Market
- 8.6.4. Australia Multimodal Imaging Market
- 8.6.5. South Korea Multimodal Imaging Market
- 8.6.6. Rest of Asia Pacific Multimodal Imaging Market
- 8.7. Latin America Multimodal Imaging Market Snapshot
- 8.7.1. Brazil Multimodal Imaging Market
- 8.7.2. Mexico Multimodal Imaging Market
- 8.8. Middle East & Africa Multimodal Imaging Market
- 8.8.1. Saudi Arabia Multimodal Imaging Market
- 8.8.2. South Africa Multimodal Imaging Market
- 8.8.3. Rest of Middle East & Africa Multimodal Imaging Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Topcon Corporation
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Recent Developments
- 9.3.2. Siemens Healthineers
- 9.3.3. Neusoft Medical Systems Co. Ltd.
- 9.3.4. United Imaging Healthcare Co. Ltd.
- 9.3.5. Infraredx Inc.
- 9.3.6. Koninklijke Philips N.V.
- 9.3.7. Canon Inc.
- 9.3.8. Mediso Medical Imaging Systems Kft
- 9.3.9. GE Healthcare
- 9.3.10. Spectrum Dynamics Medical
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption